Postherpetic neuralgia (PHN), the persistent nerve pain that lingers after a shingles rash heals, is treated with a combination of oral medications, topical patches, and sometimes nerve-targeted procedures. Most people respond to first-line options like certain anticonvulsants or topical numbing patches, though finding the right combination often takes some trial and adjustment. PHN is diagnosed when pain persists for 12 weeks or more after the shingles rash first appeared.
Why the Pain Persists After Shingles
Understanding what’s happening in your body helps explain why PHN requires targeted nerve treatments rather than standard painkillers. During a shingles outbreak, the varicella-zoster virus reactivates and travels along nerve fibers to the skin. Along the way, it triggers intense inflammation that damages the nerves themselves, the clusters of nerve cells near the spine called dorsal root ganglia, and the surrounding spinal nerves.
In people who develop PHN, this damage goes beyond temporary inflammation. Skin biopsies show significant loss of nerve endings in the affected area, and the remaining nerves become hypersensitive. They start firing pain signals even when there’s no painful stimulus, or they amplify normal sensations like clothing touching skin into burning or stabbing pain. This rewiring of pain signaling, both in the peripheral nerves and in the spinal cord itself, is why PHN requires medications that specifically target nerve function.
First-Line Medications
The most commonly prescribed oral medications for PHN are anticonvulsants: gabapentin and pregabalin. These drugs work by calming overexcited nerve membranes, reducing the volume on those misfiring pain signals. They’re typically started at low doses and gradually increased. In clinical practice, effective regimens vary widely between patients. Some people find relief with pregabalin at moderate doses taken twice daily, while others need higher doses of gabapentin spread across three daily doses, with a larger portion taken at bedtime to help with sleep.
Tricyclic antidepressants, particularly amitriptyline and nortriptyline, are another core option. These are prescribed at much lower doses than what’s used for depression, and they’re often taken at bedtime because they cause drowsiness. For many patients, the best results come from combining an anticonvulsant with a low-dose tricyclic. One typical successful combination might be gabapentin during the day paired with nortriptyline at bedtime. The drowsiness side effect actually becomes an advantage here, since sleep disruption is one of the most damaging aspects of PHN.
Topical Treatments
For people who want to avoid or supplement oral medications, two topical options target the pain directly at the skin. Lidocaine patches (5%) are applied over the painful area and numb the local nerve endings. They’re available by prescription and can be used daily, making them a practical choice for ongoing management. In studies, lidocaine patches reduced average daily pain by about 21%.
High-concentration capsaicin patches (8%) take a different approach. Capsaicin, the compound that makes chili peppers hot, overwhelms and then desensitizes the pain-transmitting nerve fibers in the skin. These patches are applied in a clinical setting for 60 minutes, with a numbing cream applied beforehand to manage the initial burning sensation. A single application can provide relief that lasts weeks, and the treatment can be repeated every 12 weeks. Studies show capsaicin patches reduce average daily pain by roughly 41%, nearly double the effect of lidocaine patches, though the application process is more involved.
The Toll on Sleep, Mood, and Daily Life
PHN doesn’t just cause pain. It disrupts nearly every aspect of daily functioning, and addressing these ripple effects is a key part of treatment. In a study across six European countries, 55% of people with shingles-related pain reported not getting enough sleep at least some of the time, and 78% of those with PHN specifically said their sleep was “not quiet.” Sleep was the single area of quality of life most affected by PHN.
The consequences cascade from there. About 31% of people with PHN reported anxiety or depression, with 11% experiencing extreme anxiety or depression. Pain also significantly interfered with enjoyment of life (31% impact), general activity (29%), mood (25%), and walking ability (8%). Chronic sleep loss below seven hours per night compounds the problem by contributing to attention lapses, cognitive difficulties, and worsening depression. This is why many treatment plans pair pain medications with sleep-supporting strategies, and why bedtime dosing of sedating medications like tricyclic antidepressants serves double duty.
When First-Line Options Aren’t Enough
If standard medications and patches don’t provide adequate relief, several second-line and interventional options exist. Tramadol, a mild opioid-like pain reliever, is recommended as a second- or third-line therapy in international guidelines, though the evidence supporting it specifically for PHN is limited. In elderly patients (75 and older), tramadol requires careful dose adjustment because the body clears it more slowly, and a high proportion of older adults discontinue it due to side effects like dizziness and nausea.
For truly refractory cases, interventional procedures become an option. Epidural steroid injections deliver anti-inflammatory medication directly near the affected spinal nerves. Research from the Mayo Clinic found that the single best predictor of a good response was how long someone had been living with PHN: those treated within 11 months of onset were significantly more likely to experience moderate-to-good pain relief 12 weeks after the injection. Patient demographics, concurrent medications, and the specific injection approach did not meaningfully affect outcomes, making early intervention the key factor.
Other interventional options include sympathetic nerve blocks, local anesthetic injections under the skin, and intrathecal injections. These are not strongly evidence-based but are used in practice when other approaches fall short. Scrambler therapy, a newer non-invasive technique, uses surface electrodes to send “non-pain” electrical signals through the same nerve pathways that carry pain, essentially attempting to retrain the nervous system. It has drawn comparisons to spinal cord stimulation, a more established but surgically implanted option for chronic pain.
How Long PHN Typically Lasts
One of the most important things to know about PHN is that it does resolve for most people. In a study following 764 patients with shingles, 12.4% still had pain at 90 days (the point at which PHN is formally diagnosed). By six months, that dropped to 7.1%, and by one year, only 4% still had ongoing pain. So even among those who develop PHN, the majority see significant improvement within the first year, particularly with active treatment. The earlier and more aggressively pain is managed, the better the long-term outlook.
Preventing PHN With Vaccination
The most effective treatment for PHN is preventing it from developing in the first place. The recombinant shingles vaccine (Shingrix) is 91% effective at preventing PHN in adults 50 and older, and 89% effective in adults 70 and older. Since 10 to 20% of people who get shingles go on to develop PHN, vaccination eliminates the vast majority of that risk. If you’ve already had shingles, the vaccine can still reduce your chances of a recurrence and subsequent PHN.